Chapter 1. Introduction
1.1. Report Description And Scope
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
Chapter 2. Executive Summary
2.1. Global Antifungal Drug Market, 2015 - 2021 (USD Billion)
2.2. Global Antifungal Drug Market: Snapshot
Chapter 3. Antifungal Drug Market Dynamics
3.1. Introduction
3.2. Value Chain Analysis
3.3. Market Drivers
3.3.1. Global Antifungal Drug Market Drivers: Impact Analysis
3.3.2. Rapid Spread Of Fungal Infection
3.3.3. Pandemicity Of Fungal Infection
3.4. Market Restraints
3.4.1. Global Antifungal Drug Market Restraints: Impact Analysis
3.4.2. High Penetration Of Conventional Drugs
3.5. Opportunities
3.5.1. Covering Untapped Market
3.6. Porters Five Forces Analysis
3.6.1. Bargaining Power Of Suppliers
3.6.2. Bargaining Power Of Buyers
3.6.3. Threat From New Entrants
3.6.4. Threat From New Substitutes
3.6.5. Degree Of Competition
3.7. Market Attractiveness Analysis
3.7.1. Market Attractiveness Analysis, By Drug Type Segment
3.7.2. Market Attractiveness Analysis, By Therapeutic Indication Segment
3.7.3. Market Attractiveness Analysis, By Dosage Form Segment
3.7.4. Market Attractiveness Analysis, By Regional Segment
Chapter 4. Global Antifungal Drug Market Competitive Landscape
4.1. Company Market Share, 2015 (Subject To Data Availability)
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Type Launch
4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
4.2.4. Research And Development, Regional Expansion
4.3. Type Portfolio
Chapter 5. Global Antifungal Drug Market Test Analysis
5.1. Global Antifungal Drug Market: Test Overview
5.1.1. Global Antifungal Drug Market Revenue Share, By Test , 2015 And 2021
5.2. Echinocandins
5.2.1. Global Echinocandins Testing Market, 2015 2021 (USD Billion)
5.3. Azoles
5.3.1. Global Azoles Market, 2015 2021 (USD Billion)
5.4. Ployenes
5.4.1. Global Ployenes Market, 2015 2021 (USD Billion)
5.5. Allylamines
5.5.1. Global Allylamines Market, 2015 2021 (USD Billion)
5.6. Others
5.6.1. Global Other Antifungal Drug Market, 2015 2021 (USD Billion)
Chapter 6. Global Antifungal Drug Market Therapeutic Indication Analysis
6.1. Global Antifungal Drug Market: Therapeutic Indication Segment Overview
6.1.1. Global Antifungal Drug Market Revenue Share, By Therapeutic Indication, 2015 And 2021
6.2. Aspergillosis
6.2.1. Global Antifungal Drug Market For Aspergillosis, 2015 2021 (USD Billion)
6.3. Dermatophytosis
6.3.1. Global Antifungal Drug Market For Dermatophytosis, 2015 2021 (USD Billion)
6.4. Candidiasis
6.4.1. Global Antifungal Drug Market For Candidiasis, 2015 2021 (USD Billion)
6.5. Others
6.5.1. Global Antifungal Drug For Others Therapeutic Indication Market, 2015 2021 (USD Billion)
Chapter 7. Global Antifungal Drug Market Dosage Form Analysis
7.1. Global Antifungal Drug Market: Dosage Form Segment Overview
7.1.1. Global Antifungal Drug Market Revenue Share, By Dosage Form, 2015 And 2021
7.2. Powders
7.2.1. Global Antifungal Drug Market For Powders, 2015 2021 (USD Billion)
7.3. Ointment
7.3.1. Global Antifungal Drug For Ointment Market, 2015 2021 (USD Billion)
7.4. Drugs
7.4.1. Global Antifungal Drug Market For Drugs, 2015 2021 (USD Billion)
7.5. Paste
7.5.1. Global Antifungal Drug For Paste Market, 2015 2021 (USD Billion)
Chapter 8. Global Antifungal Drug Market Regional Segment Analysis
8.1. Global Antifungal Drug Market: Regional Overview
8.1.1. Global Antifungal Drug Market Revenue Share, By Region, 2015 And 2021
8.2. North America
8.2.1. North America Antifungal Drug Market Revenue, By Drug Type , 2015 2021 , (USD Billion)
8.2.2. North America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 , (USD Billion)
8.2.3. North America Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 , (USD Billion)
8.2.4. U.S.
8.2.4.1. U.S. Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.2.5. U.S.
8.2.5.1. U.S. Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.2.6. U.S.
8.2.6.1. U.S. Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.3. Europe
8.3.1. Europe Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.3.2. Europe Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.3.3. Europe Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.3.4. Germany
8.3.4.1. Germany Antifungal Drug Market Revenue, By Drug Type , 2015 2021, (USD Billion)
8.3.4.2. Germany Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021, (USD Billion)
8.3.4.3. Germany Antifungal Drug Market Revenue, By Dosage Form , 2015 2021, (USD Billion)
8.3.5. France
8.3.5.1. France Antifungal Drug Market Revenue, By Drug Type , 2015 2021, (USD Billion)
8.3.5.2. France Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021, (USD Billion)
8.3.5.3. France Antifungal Drug Market Revenue, By Dosage Form , 2015 2021, (USD Billion)
8.3.6. UK
8.3.6.1. UK Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.3.6.2. UK Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.3.6.3. UK Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.4.2. Asia Pacific Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.4.3. Asia Pacific Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.4.4. China
8.4.4.1. China Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.4.4.2. China Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.4.4.3. China Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.4.5. Japan
8.4.5.1. Japan Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.4.5.2. Japan Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.4.5.3. Japan Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.4.6. India
8.4.6.1. India Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.4.6.2. India Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.4.6.3. India Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.5. Latin America
8.5.1. Latin America Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.5.2. Latin America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.5.3. Latin America Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.5.4. Brazil
8.5.4.1. Brazil Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.5.4.2. Brazil Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.5.4.3. Brazil Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
8.6. Middle East And Africa
8.6.1. Middle East And Africa Antifungal Drug Market Revenue, By Drug Type , 2015 2021 (USD Billion)
8.6.2. Middle East And Africa Antifungal Drug Market Revenue, By Therapeutic Indication, 2015 2021 (USD Billion)
8.6.3. Middle East And Africa Antifungal Drug Market Revenue, By Dosage Form , 2015 2021 (USD Billion)
Chapter 9. Company Profile
9.1. Asperqillus
9.1.1. Overview
9.1.2. Financials
9.1.3. Product Portfolio
9.1.4. Business Strategy
9.1.5. Recent Developments
9.2. Alternaria
9.2.1. Overview
9.2.2. Financials
9.2.3. Product Portfolio
9.2.4. Business Strategy
9.2.5. Recent Developments
9.3. Abbott Laboratories
9.3.1. Overview
9.3.2. Financials
9.3.3. Product Portfolio
9.3.4. Business Strategy
9.3.5. Recent Developments
9.4. Pfizer
9.4.1. Overview
9.4.2. Financials
9.4.3. Product Portfolio
9.4.4. Business Strategy
9.4.5. Recent Developments
9.5. Glaxosmithkline
9.5.1. Overview
9.5.2. Financials
9.5.3. Product Portfolio
9.5.4. Business Strategy
9.5.5. Recent Developments
9.6. Bayer Healthcare
9.6.1. Overview
9.6.2. Financials
9.6.3. Product Portfolio
9.6.4. Business Strategy
9.6.5. Recent Developments
9.7. Novartis
9.7.1. Overview
9.7.2. Financials
9.7.3. Product Portfolio
9.7.4. Business Strategy
9.7.5. Recent Developments
9.8. Sanofi-Aventis
9.8.1. Overview
9.8.2. Financials
9.8.3. Product Portfolio
9.8.4. Business Strategy
9.8.5. Recent Developments
9.9. Merck Co.
9.9.1. Overview
9.9.2. Financials
9.9.3. Product Portfolio
9.9.4. Business Strategy
9.9.5. Recent Developments
9.10. Kramer Laboratories
9.10.1. Overview
9.10.2. Financials
9.10.3. Product Portfolio
9.10.4. Business Strategy
9.10.5. Recent Developments